POMMADE AU THE DES BOIS 760 MG / 100 G — DIN 00595950
CAMPHOR : 760 MG / 100 G MENTHOL : 760 MG / 100 G EUCALYPTOL : 520 MG / 100 G METHYL SALICYLATE : 15 G / 100 G · LAB VALMO ENREGISTRÉ, DIVISION OF TECHNILAB INC. · EMULSION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is POMMADE AU THE DES BOIS?
POMMADE AU THE DES BOIS 760 MG / 100 G contains CAMPHOR : 760 MG / 100 G MENTHOL : 760 MG / 100 G EUCALYPTOL : 520 MG / 100 G METHYL SALICYLATE : 15 G / 100 G. It is listed in the Health Canada Drug Product Database under DIN 00595950, held by LAB VALMO ENREGISTRÉ, DIVISION OF TECHNILAB INC., supplied as EMULSION for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 17-Sep-1999. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Preparations With Salicylic Acid Derivatives in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
74 holders have a Canadian DIN containing Preparations With Salicylic Acid Derivatives, across 120 DINs, of which 11 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| CRLS | 4 | 4 | FLEXACRÈME PAIN RELIEF RUB, PAIN RELIEF CREAM EXTRA STRENGTH, PAIN RELIEF CREAM REGULAR STRENGTH, PAIN RELIEF RUB TRIETHANOLAMINE SALICYLATE CREAM | Sourceable in Canada |
| CHURCH & DWIGHT CANADA CORP | 7 | 3 | ARTHRITIS EXTRA STRENGTH ROLL-ON LOTION, ARTHRITIS PAIN RELIEF, MUSCLE & JOINT NO ODOUR EXTRA STRENGTH, MUSCLE & JOINT NO ODOUR REGULAR STRENGTH, NO ODOUR CREAM, +2 more | Sourceable in Canada |
| EXZELL PHARMA INC | 3 | 3 | MYOFLEX EXTRA STRENGTH, MYOFLEX MAXIMUM STRENGTH, MYOFLEX REGULAR STRENGTH | Sourceable in Canada |
| SANOFI CONSUMER HEALTH INC | 2 | 1 | ASPERCREME CREME RUB 10%, EXTRA STRENGTH ASPERCREME CREME RUB 15% | Sourceable in Canada |
| BAYER INC CONSUMER CARE | 7 | 0 | MYOFLEX ARTHRITIC CREAM, MYOFLEX DEEP THERAPY, MYOFLEX EXTRA CREAM, MYOFLEX EXTRA STRENGTH ICE, MYOFLEX ICE COLD PLUS - GEL, +2 more | No marketed DIN |
| STERLING WINTHROP INC. | 4 | 0 | MYOFLEX ARTHRITIC CREAM 15%, MYOFLEX EXTRA CREAM 15%, MYOFLEX ICE COLD PLUS - GEL, MYOFLEX REGULAR CREAM 10% | No marketed DIN |
| CARTER PRODUCTS, DIVISION OF CARTER WALLACE NS INC. | 3 | 0 | ANTIPHLOGISTINE RUB A 535 EXTRA STRENGTH, ANTIPHLOGISTINE RUB A-535 NO ODOUR FMLA ONT, ANTIPHLOGISTINE RUB A535 | No marketed DIN |
| HISAMITSU PHARMACEUTICAL CO., INC. | 3 | 0 | SALONPAS - PLS TOP, SALONPAS GEL-PATCH, SALONPAS MEDICATED PLASTER | No marketed DIN |
| PHARMASCIENCE INC | 3 | 0 | ANALGESIC CREAM, ANALGESIC CREAM EXTRA STRENGTH ODORLESS, FLEXACRÈME EXTRA-STRENGTH | No marketed DIN |
| PRODEMDIS ENR. | 3 | 0 | CAM SUN (HUILE THERAPEUTIQUE), FLEXACREME, MEDICATED ANALGESIC CREAM | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 3 | 0 | ANALGESIC BALM, HEAT RUB, WINTERGREEN OIL OF | No marketed DIN |
| STELLA PHARMACEUTICAL CANADA INC. | 3 | 0 | ASPERCREME 10%, ASPERCREME EXTRA STRENGTH CRM RUB, MINARD'S JOINT RELIEF | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 760 MG / 100 G |
|---|---|
| Dosage form | EMULSION |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Preparations With Salicylic Acid Derivatives |
|---|---|
| ATC code | M02AC |
| AHFS class | 28:08.04.24 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00595950 |
|---|---|
| DIN (unpadded, as printed on some documents) | 595950 |
| Brand name | POMMADE AU THE DES BOIS |
| Generic / active ingredient | CAMPHOR : 760 MG / 100 G MENTHOL : 760 MG / 100 G EUCALYPTOL : 520 MG / 100 G METHYL SALICYLATE : 15 G / 100 G |
| Market authorization holder | LAB VALMO ENREGISTRÉ, DIVISION OF TECHNILAB INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AC |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M02AC |
| Current status | CANCELLED POST MARKET |
| Status date | 17-Sep-1999 |
| Original market date | 1986-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
11 of 120 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARTHRITIS PAIN RELIEF | 10 % | LOTION | CHURCH & DWIGHT CANADA CORP | MARKETED | 02486725 |
| EXTRA STRENGTH ASPERCREME CREME RUB 15% | 15 % | CREAM | SANOFI CONSUMER HEALTH INC | MARKETED | 02074702 |
| FLEXACRÈME PAIN RELIEF RUB | 15 % | CREAM | CRLS | MARKETED | 02516713 |
| MUSCLE & JOINT NO ODOUR EXTRA STRENGTH | 20 % | CREAM | CHURCH & DWIGHT CANADA CORP | MARKETED | 02473135 |
| MUSCLE & JOINT NO ODOUR REGULAR STRENGTH | 13.3 % | CREAM | CHURCH & DWIGHT CANADA CORP | MARKETED | 02473143 |
| MYOFLEX EXTRA STRENGTH | 15 % | CREAM | EXZELL PHARMA INC | MARKETED | 02226022 |
| MYOFLEX MAXIMUM STRENGTH | 20 % | CREAM | EXZELL PHARMA INC | MARKETED | 02244573 |
| MYOFLEX REGULAR STRENGTH | 10 % | CREAM | EXZELL PHARMA INC | MARKETED | 02152827 |
| PAIN RELIEF CREAM EXTRA STRENGTH | 20 % | CREAM | CRLS | MARKETED | 02413442 |
| PAIN RELIEF CREAM REGULAR STRENGTH | 13.3 % | CREAM | CRLS | MARKETED | 02358131 |
2 · Same class — other molecules in ATC M02AC
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Preparations With Salicylic Acid Derivatives | ACTIFLEX PAIN RELIEF RUB · ALCIS TOPICAL PAIN RELIEF CREAM · ALGESAL CRM 10% · ALSIRUB ONT · +113 more | 120 | 11 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M02AA | Bufexamac · Diclofenac | 16 | 8 |
| M02AB | Capsaicin · Capsaicin And Similar Agents · Zucapsaicin | 26 | 0 |
| M02AX | Dimethyl Sulfoxide · Various | 60 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.